Source: Getty Images
We’ve done a lot of pivoting in the past year, from going to work and going to school to doing both from home. We’ve pivoted from large gatherings and public events to wearing masks and staying six feet apart and watching much of the world go by on television. Front-line workers had to pivot quickly to 24/7 crisis mode with no work-from-home option.
We are now pivoting again in the United States, from a scenario of vaccine demand exceeding supply to one of supply soon exceeding demand. Those who were frantically scrambling for vaccine appointments a couple of months ago can now find them with relative ease. Meanwhile, the CDC has relaxed its guidance on wearing masks outdoors, mostly for the fully vaccinated, while telling us all to keep masking up in indoor public places and outdoor events with big crowds.
LamiadLamai / iStock
The pandemic isn t over yet, but with more and more Americans getting vaccinated against COVID-19 and the light at the end of the pandemic tunnel becoming a little brighter every day at least in the United States many clinicians, scientists, and public health advocates are calling for renewed attention to an infectious disease threat that was in the spotlight before the pandemic arrived.
Prior to the pandemic, antimicrobial resistance (AMR) was considered one of the major looming health threats facing the world, if not
the looming threat. But over the past year, COVID-19, and its multifaceted impact on society, has pushed AMR further back on the agenda, both for the public and policy makers.
Experts predict US COVID-19 cases will dip in summer but surge in winter
As with other respiratory viruses, when cold weather drives more people back inside, cases and deaths could surge again, said Ali Mokdad, a public health researcher at the University of Washington’s Institute for Health Metrics and Evaluation in Seattle.
Written By:
Tina Hesman Saey / Science News | 7:10 pm, Apr. 26, 2021 ×
This transmission electron microscope image shows SARS-CoV-2, the virus that causes COVID-19, isolated from a patient in the U.S., emerging from the surface of cells cultured in the lab.
NIAID / Tribune News Service
The coming months of the COVID-19 pandemic in the United States may feel a bit like a roller-coaster ride.
While Covid vaccines help curb the pandemic, researchers are working on an antiviral pill
SECTIONS
Last Updated: Apr 27, 2021, 06:07 PM IST
Share
iStock
Developing drugs for respiratory diseases is tough, partly because doses have to be high enough for the medicine to reach deep into the lungs yet not so high that they re toxic.
Related
If Priscila Medina had gotten COVID-19 a year ago, she would have had no treatments proven safe and effective to try. But when the 30-year-old nurse arrived at a Long Island hospital last month, so short of breath she could barely talk, doctors knew just what to do.
Jack Remington, infectious-disease expert and clinician, dies at 90
The Stanford physician devised a test that saved babies’ lives by showing whether they needed immediate treatment for a parasitic disease called toxoplasmosis. Apr 27 2021
Jack Remington
Jack Remington, MD, professor emeritus of infectious diseases at Stanford Medicine, died April 8 in Menlo Park, California, of complications from an injury he sustained in a fall. He was 90.
An extreme-sports enthusiast with a penchant for mountain climbing, which over the years exacted a physical toll on his body, Remington was a hard-charging patient advocate who put his patients’ needs above all else.
He was also an accomplished scientist who conducted groundbreaking research on